David Wen

Discovery of 3-[2-(Imidazo[1,2-<i>b</i>]pyridazin-3-yl)ethynyl]-4-methyl-<i>N</i>-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant

Wei‐Sheng Huang, Chester A. Metcalf, Raji Sundaramoorthi et al. · Journal of Medicinal Chemistry · 2010 · 357 citations · Full text

Drug Target, Immunology, Molecular Biology +25

Self-activation of cellulose: A new preparation methodology for activated carbon electrodes in electrochemical capacitors

Clement Bommier, Rui Xu, Wei Wang et al. · Nano Energy · 2015 · 131 citations · Full text

Activated Carbon Electrodes, Chemical Engineering, Engineering +7

Long‐term results after primary frontal sinus surgery

Yuresh Naidoo, David Wen, Ahmed Bassiouni et al. · International Forum of Allergy & Rhinology · 2012 · 63 citations

Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors

Yihan Wang, William C. Shakespeare, Wei‐Sheng Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 32 citations · Full text

Novel N9-arenethenyl Purines, Medicinal Chemistry, Biochemistry +10

Synthesis and properties of chemiluminescent acridinium ester labels with fluorous tags

Anand Natrajan, David Wen, David Sharpe · Organic & Biomolecular Chemistry · 2014 · 25 citations